🔗 Permalink

Inventor profile of:

Patrick Hwu

City:

Houston, Texas

Country:

United States

Published Applications:

Last publication date:

2024-01-11

Top Assignees for applications by Patrick Hwu

The entities that hold a legal rights for patent applications filed by inventor Hwu Patrick:

Board of Regents, The University of Texas System 8 Austin, TX United States
MEMGEN, Inc. 2 Houston, TX United States
Memgen, LLC 2 Houston, TX United States
NanoCruise Pharmaceutical Ltd. 1 Jiangsu, China
and Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Washington, DC United States
The United States of America as Represented by the Department of Health and Human Services 1 Washington, DC United States
GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. 1 Rockville, MD United States
THE US OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES 1 Bethesda, MD United States
Board of Regents of the University of Texas System 1 Austin, TX United States
The USA, as represented by the Secretary, Dept. of Health and Human Services 1 Bethesda, MD United States
The United States of America as represented by the Secretary of the Department of Health and Human Services 1 Washington, DC United States

Recent patent applications by Hwu Patrick

Patrick Hwu from Houston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-11

US20240009241A1

Human necessities

ENGINEERED T CELL RECEPTORS TARGETING EGFR ANTIGENS AND METHODS OF USE

#2 | 2024-01-11

US20240009240A1

Human necessities

ENGINEERED T CELL RECEPTORS TARGETING EGFR ANTIGENS AND METHODS OF USE

#3 | 2023-09-14

US20230285558A1

Human necessities

ENGINEERED T CELLS AND TUMOR-INFILTRATING LYMPHOCYTES TO INCREASE TUMOR KILLING

#4 | 2023-04-06

US20230106973A1

Chemistry; metallurgy

METHODS FOR EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF

#5 | 2022-12-29

US20220409663A1

Human necessities

ENGINEERED T CELLS AND TUMOR-INFILTRATING LYMPHOCYTES TO OVERCOME IMMUNOSUPPRESSION IN THE TUMOR MICROENVIRONMENT

#6 | 2021-07-08

US20210205293A1

Human necessities

COMBINATION OF TOPOISOMERASE-I INHIBITORS WITH IMMUNOTHERAPY IN THE TREATMENT OF CANCER

#7 | 2021-06-10

US20210172961A1

Physics

METHODS FOR IDENTIFYING RNA EDITING-DERIVED EPITOPES THAT ELICIT IMMUNE RESPONSES IN CANCER

#8 | 2021-06-10

US20210170002A1

Human necessities

SLC45A2 PEPTIDES FOR IMMUNOTHERAPY

#9 | 2020-11-12

US20200353044A1

Human necessities

Methods of CD40 and toll like receptor immune activation

#10 | 2020-05-28

US20200165339A1

Chemistry; metallurgy

Methods of CD40 activation and immune checkpoint blockade

#11 | 2020-04-16

US20200115466A1

Chemistry; metallurgy

Monoclonal and humanized antibodies to a cancer glycopeptide

#12 | 2019-09-12

US20190275133A1

Human necessities

IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD

#13 | 2019-06-06

US20190169262A1

Chemistry; metallurgy

SLC45A2 PEPTIDES FOR IMMUNOTHERAPY

#14 | 2018-09-20

US20180263971A1

Human necessities

Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

#15 | 2017-12-21

US20170363629A1

Physics

BIOMARKERS AND TARGETS FOR CANCER IMMUNOTHERAPY

#16 | 2013-11-14

US20130302300A1

Chemistry; metallurgy

B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

#17 | 2012-12-06

US20120309691A1

Human necessities

TUMOR TARGETED DELIVERY OF IMMUNOMODULATORS BY NANOPOLYMERS

#18 | 2010-11-04

US20100279950A1

Chemistry; metallurgy

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

#19 | 2010-06-24

US20100158881A1

Chemistry; metallurgy

ACTIVATED DUAL SPECIFICITY LYMPHOCYTES AND THEIR METHODS OF USE

#20 | 2010-06-03

US20100135958A1

Human necessities

METHOD FOR TREATING CANCER IN HUMANS

#21 | 2009-01-08

US20090010953A1

Chemistry; metallurgy

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

#22 | 2005-03-24

US20050065077A1

Chemistry; metallurgy

Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods

#23 | 2005-03-24

US20050063947A1

Human necessities

Method for treating cancer in humans

InventorID:

528244 ⎘